ASH 2019: Dr. Jennifer Brown on Using Ibrutini... - CLL Support

CLL Support

23,250 members39,937 posts

ASH 2019: Dr. Jennifer Brown on Using Ibrutinib After Progressing on Venetoclax for Ibrutinib-Naïve Patients with CLL

bkoffman profile image
bkoffmanCLL CURE Hero
0 Replies

cllsociety.org/2020/05/ash-...

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

Dr. John Allan - Chronic Lymphocytic Leukemia (CLL) Patients @Undetectable Measurable Residual Disease (MRD) after Ibrutinib Plus Venetoclax

ASH 2022: Dr. John Allan on Outcomes for Chronic Lymphocytic Leukemia (CLL) Patients with...
lankisterguy profile image
Volunteer

ASH 2019: U-MRD by subgroup (ibrutinib+venetoclax) CAPTIVATE trial

This is how we achieve personalized, precision medicine. 73% of patients achieved U-MRD4 in BM...
avzuclav profile image

Zanubrutinib vs. Ibrutinib Patient Power Video by Dr. Jennifer Brown MD PHD

In this Patient Power video - Dr. Brown is very clear about the advantages of Zanubrutinib over...
lankisterguy profile image
Volunteer

New Clinical Trial of Ibrutinib + Venetoclax for people relapsing on Ibrutinib

Yesterday I started a new clinical trial at UCSD for people that have relapsed on Ibrutinib. I had...
Teegolf47 profile image

ASH 2016: Dr. Mato on real world data on ibrutinib

Hi, This week I'm posting an interview that I had with Dr. Anthony Mato from U Penn when we talked...
bkoffman profile image
CLL CURE Hero

Moderation team

See all
AussieNeil profile image
AussieNeilAdministrator
CLLerinOz profile image
CLLerinOzAdministrator
Newdawn profile image
NewdawnAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.